{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:45:49Z","timestamp":1753519549081},"reference-count":29,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.3892\/mmr.2014.2657","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T03:48:56Z","timestamp":1413344936000},"page":"317-326","source":"Crossref","is-referenced-by-count":12,"title":["Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro"],"prefix":"10.3892","volume":"11","author":[{"given":"YULAN","family":"YAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BING","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YANG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUEFENG","family":"BU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,10,15]]},"reference":[{"key":"key20180108001731_b1-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"American Cancer Society: Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"key20180108001731_b2-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3322\/caac.21173","article-title":"Cancer statistics for African Americans, 2013","volume":"63","author":"DeSantis","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20180108001731_b3-mmr-11-01-0317","first-page":"316","article-title":"The treatment of lung carcinoma in aged people","volume":"4","author":"Zhang","year":"2001","journal-title":"Chin J Geriatr"},{"key":"key20180108001731_b4-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2007.02.002","article-title":"Oncolytic viruses in cancer therapy","volume":"254","author":"V\u00e4h\u00e4-Koskela","year":"2007","journal-title":"Cancer Letters"},{"key":"key20180108001731_b5-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"718710","DOI":"10.1155\/2011\/718710","article-title":"Safety and clinical usage of newcastle disease virus in cancer therapy","volume":"2011","author":"Lam","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"key20180108001731_b6-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/03079450120078626","article-title":"Newcastle disease virus: macromolecules and opportunities","volume":"30","author":"Yusoff","year":"2001","journal-title":"Avian Pathol"},{"issue":"Pt 11","key":"key20180108001731_b7-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1099\/vir.0.19416-0","article-title":"Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity","volume":"84","author":"R\u00f6mer-Oberd\u00f6rfer","year":"2003","journal-title":"J Gen Virol"},{"key":"key20180108001731_b8-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000328325","article-title":"Apoptin enhances the oncolytic properties of Newcastle disease virus","volume":"55","author":"Wu","year":"2012","journal-title":"Intervirology"},{"key":"key20180108001731_b9-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0042-6822(64)90259-4","article-title":"Early stages of newcastle disease virus-hela cell interaction: an electron microscopic study","volume":"23","author":"Silverstein","year":"1964","journal-title":"Virology"},{"key":"key20180108001731_b10-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00705-002-0877-4","article-title":"Phylogenetic comparison of the genus lyssavirus using distal coding sequences of the glycoprotein and nucleoprotein genes","volume":"147","author":"Johnson","year":"2002","journal-title":"Arch Virol"},{"key":"key20180108001731_b11-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1128\/JVI.77.19.10537-10547.2003","article-title":"Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis","volume":"77","author":"Pr\u00e9haud","year":"2003","journal-title":"J Virol"},{"key":"key20180108001731_b12-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1128\/JVI.00519-11","article-title":"Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats","volume":"85","author":"Ge","year":"2011","journal-title":"J Virol"},{"key":"key20180108001731_b13-mmr-11-01-0317","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"key20180108001731_b14-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000264198","article-title":"Newcastle disease virus infection promotes bax redistribution to mitochondria and cell death in HeLa cells","volume":"53","author":"Molouki","year":"2010","journal-title":"Intervirology"},{"key":"key20180108001731_b15-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s11064-011-0529-8","article-title":"Cytolytic effects and apoptosis induction of Newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line","volume":"36","author":"Ali","year":"2011","journal-title":"Neurochem Res"},{"key":"key20180108001731_b16-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF03401771","article-title":"A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle diseasevirus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire","volume":"4","author":"Batliwalla","year":"1998","journal-title":"Mol Med"},{"key":"key20180108001731_b17-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1200\/JCO.2002.08.042","article-title":"Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers","volume":"20","author":"Pecora","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180108001731_b18-mmr-11-01-0317","first-page":"635","article-title":"Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68\/H)","volume":"19","author":"Csatary","year":"1999","journal-title":"Anticancer Res"},{"key":"key20180108001731_b19-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymthe.2005.08.016","article-title":"Phase I\/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme","volume":"13","author":"Freeman","year":"2006","journal-title":"Mol Ther"},{"key":"key20180108001731_b20-mmr-11-01-0317","first-page":"507","article-title":"Newcastle disease virus as an oncolytic agent","volume":"130","author":"Ravindra","year":"2009","journal-title":"Indian J Med Res"},{"key":"key20180108001731_b21-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/ijc.22215","article-title":"Antitumor effects of a recombinant fowlpox virus expressing apoptin in vivo and in vitro","volume":"119","author":"Li","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180108001731_b22-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/sj.gt.3300876","article-title":"Specific tumor-cell killing with adenovirus vectors containing the apoptin gene","volume":"6","author":"Pietersen","year":"1999","journal-title":"Gene Ther"},{"key":"key20180108001731_b23-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000328325","article-title":"Apoptin enhances the oncolytic properties of Newcastle disease virus","volume":"55","author":"Wu","year":"2012","journal-title":"Intervirology"},{"key":"key20180108001731_b24-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virusres.2008.04.020","article-title":"Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy","volume":"136","author":"Zhao","year":"2008","journal-title":"Virus Res"},{"key":"key20180108001731_b25-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virusres.2008.01.010","article-title":"Induction of apoptosis in Vero cells by Newcastle disease virus requires viral replication, de-novo protein synthesis and caspase activation","volume":"133","author":"Ravindra","year":"2008","journal-title":"Virus Res"},{"key":"key20180108001731_b26-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/fmb.12.4","article-title":"Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions","volume":"7","author":"Zamarin","year":"2012","journal-title":"Future Microbiol"},{"key":"key20180108001731_b27-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1128\/JVI.00241-06","article-title":"Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death","volume":"80","author":"Elankumaran","year":"2006","journal-title":"J Virol"},{"key":"key20180108001731_b28-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1027339418683","article-title":"Role of the mitochondrial permeability transition pore in apoptosis","volume":"17","author":"Hirsch","year":"1997","journal-title":"Biosci Rep"},{"key":"key20180108001731_b29-mmr-11-01-0317","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1465-9921-6-29","article-title":"Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells","volume":"6","author":"Plummer","year":"2005","journal-title":"Respir Res"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2657\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T02:08:04Z","timestamp":1565921284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,15]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,10,15]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.3892\/mmr.2014.2657"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2657","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,15]]}}}